On Wednesday, the S&P 500 was down 0.6% and Toronto was down a full percentage point.
Valeant Pharmaceuticals, which was added to this site rated Sell on July 30 at $331 is down to $154. I had concerns about both the valuation and the trustworth...
Members only content
The content on this page is for members only. If you are a member, log in below. If you are not a member, please Register.